Mesenchymal Stem Cell Senescence and Rejuvenation: Current Status and Challenges

Area of Science:

• Regenerative Medicine
• Cell Biology
• Gerontology

Background:

• Mesenchymal stem cells (MSCs) are widely studied for treating diseases due to their differentiation and immunomodulatory properties.
• Clinical trials show MSC potential, but allogeneic MSCs face rejection, and autologous MSCs decline with age (senescence).

Purpose of the Study:

• To review the biological features of senescent MSCs.
• To explore molecular mechanisms driving MSC senescence.
• To summarize current strategies for rejuvenating senescent MSCs.

Main Methods:

• Literature review of studies on MSC senescence.
• Analysis of mechanisms including epigenetic changes, autophagy, mitochondrial dysfunction, and telomere shortening.
• Overview of rejuvenation approaches like gene modification and pretreatment.

Main Results:

• MSC senescence impairs their therapeutic efficacy, particularly in elderly patients.
• Key mechanisms contributing to senescence include epigenetic alterations, impaired autophagy, mitochondrial dysfunction, and telomere shortening.
• Various strategies are being developed to reverse or mitigate MSC senescence.

Conclusions:

• Understanding MSC senescence mechanisms is vital for developing effective cell-based therapies.
• Rejuvenating senescent MSCs offers a promising avenue to enhance autologous MSC therapy, especially for age-related conditions.
• Optimizing MSC function through rejuvenation could significantly improve patient outcomes in regenerative medicine.